Atlas Trials

A Study to Assess the Safety of ARGX-213 in Healthy Volunteers

Clinical trial NCT06968338 · COMPLETED

Trial details

NCT number
NCT06968338
Sponsor
argenx
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2025-04-11
Primary completion
2026-03-20
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.